ATE293958T1 - Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküle - Google Patents
Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküleInfo
- Publication number
- ATE293958T1 ATE293958T1 AT98932506T AT98932506T ATE293958T1 AT E293958 T1 ATE293958 T1 AT E293958T1 AT 98932506 T AT98932506 T AT 98932506T AT 98932506 T AT98932506 T AT 98932506T AT E293958 T1 ATE293958 T1 AT E293958T1
- Authority
- AT
- Austria
- Prior art keywords
- microparticles
- biologically active
- controlled delivery
- active molecules
- synthetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000418A IT1293088B1 (it) | 1997-07-10 | 1997-07-10 | Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in |
PCT/IT1998/000192 WO1999002135A1 (en) | 1997-07-10 | 1998-07-09 | Microparticles for controlled delivery of biologically active molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE293958T1 true ATE293958T1 (de) | 2005-05-15 |
Family
ID=11405168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98932506T ATE293958T1 (de) | 1997-07-10 | 1998-07-09 | Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküle |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1003482B1 (de) |
AT (1) | ATE293958T1 (de) |
AU (1) | AU8240998A (de) |
DE (1) | DE69829975T2 (de) |
ES (1) | ES2242287T3 (de) |
IT (1) | IT1293088B1 (de) |
WO (1) | WO1999002135A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1407787B1 (de) | 2001-06-20 | 2009-04-29 | Dainippon Sumitomo Pharma Co., Ltd. | Verfahren zur förderung des nukleinsäuretransfers |
JP2008067717A (ja) * | 2001-06-20 | 2008-03-27 | Dainippon Sumitomo Pharma Co Ltd | 核酸導入を促進させる方法 |
US7166575B2 (en) | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
US7229966B2 (en) | 2002-12-17 | 2007-06-12 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
EP1581245A2 (de) | 2002-12-17 | 2005-10-05 | Nastech Pharmaceutical Company Inc. | Zusammensetzungen und verfahren für verstärkte mukosale abgabe von y2-rezeptorbindenden peptiden sowie verfahren zur behandlung und prävention von adipositas |
US7186692B2 (en) | 2002-12-17 | 2007-03-06 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |
EP3370694A1 (de) | 2015-11-06 | 2018-09-12 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | Zusammensetzung mit einem biokompatiblen und biologisch abbaubaren polymer, nanoträger und arzneimittel sowie verfahren zur herstellung und verwendung davon |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2660556B1 (fr) * | 1990-04-06 | 1994-09-16 | Rhone Poulenc Sante | Microspheres, leur procede de preparation et leur utilisation. |
IT1244511B (it) * | 1991-04-15 | 1994-07-15 | Isi Ist Sierovaccinogeno Ital | Idrogeli a base di policarbossilati sintetici e proteine per il rilascio controllato di farmaci e procedimento per la loro preparazione. |
ATE222500T1 (de) * | 1992-06-11 | 2002-09-15 | Alkermes Inc | Enythropoietin enthaltendes arzneimittelabgabesystem |
AU6707194A (en) * | 1993-04-19 | 1994-11-08 | Medisorb Technologies International L.P. | Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
-
1997
- 1997-07-10 IT IT97RM000418A patent/IT1293088B1/it active IP Right Grant
-
1998
- 1998-07-09 AU AU82409/98A patent/AU8240998A/en not_active Abandoned
- 1998-07-09 AT AT98932506T patent/ATE293958T1/de not_active IP Right Cessation
- 1998-07-09 ES ES98932506T patent/ES2242287T3/es not_active Expired - Lifetime
- 1998-07-09 EP EP98932506A patent/EP1003482B1/de not_active Expired - Lifetime
- 1998-07-09 DE DE69829975T patent/DE69829975T2/de not_active Expired - Lifetime
- 1998-07-09 WO PCT/IT1998/000192 patent/WO1999002135A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ES2242287T3 (es) | 2005-11-01 |
EP1003482A1 (de) | 2000-05-31 |
WO1999002135A1 (en) | 1999-01-21 |
ITRM970418A0 (de) | 1997-07-10 |
DE69829975D1 (de) | 2005-06-02 |
EP1003482B1 (de) | 2005-04-27 |
DE69829975T2 (de) | 2006-03-09 |
AU8240998A (en) | 1999-02-08 |
ITRM970418A1 (it) | 1999-01-10 |
IT1293088B1 (it) | 1999-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69938552D1 (de) | Spritzgiessbare feste verabreichungsysteme | |
DK1367944T3 (da) | Plaster til skanning af et individs overfölsomhedstilstand for et allergen | |
DE69820268D1 (de) | Implantierbare vorrichtung mit einer polymerbeschichtung zur freisetzung von biologisch wirksamen stoffen | |
DE502004011156D1 (de) | Endovaskuläres implantat mit einer zumindest abschnittsweisen aktiven beschichtung aus ratjadon und/oder einem ratjadon-derivat | |
DE50207501D1 (de) | Biologisch funktionalisierte, metabolisch induktive implantatoberflächen | |
ATE368054T1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
EA200000278A1 (ru) | Композиционный материал на основе бумаги с полимерным покрытием | |
DE69801517T2 (de) | Verfahren zur verhinderung der verkalkung von aldehyd-fixierten bioprothesenmaterialien | |
SE9201128L (sv) | Artificiellt fyllnings- och protesmaterial | |
DE69821510D1 (de) | Mit apatit beschichtete feste zusammensetzung | |
DE69826354D1 (de) | Wässrige Fluoropolymerdispersion und Verfahren zur Herstellung von Fluorpolymer-enthaltenden, thermoplastischen Harzzusammensetzungen | |
BR0107942A (pt) | Polìmeros de proteìna de liberação lenta | |
DE69832166D1 (de) | Matrix zur trennung und nutzung der matrix zur trennung | |
DE69832293D1 (de) | Zubereitungen zur abgabe von negativ geladenen molekülen | |
ID22415A (id) | Turunan-turunan 8-azabisiklo [3,2,1] oktana, 8-azabisiklo [3,2,1] okt-6-ena, 9-azabisiklo [3,3,1]- nonana, 9-aza-3-oksabisiklo [3,3,1] nonana, 9-aza-3-tiabisiklo [3,3,1] nonana, pembuatan dan penggunaannya sebagai insektisida | |
DE59506057D1 (de) | Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen | |
ATE293958T1 (de) | Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküle | |
ATE282474T1 (de) | Infusionsdüse | |
DE60018564D1 (de) | Funktionsfähige poly-alpha-aminosäurederivate zur modifizierung von biologisch wirksamen stoffen und deren herstellung | |
PE101199A1 (es) | Estructura absorbente comprendiendo un polimero sumamente absorbente y un articulo que comprende la estructura absorbente | |
ES2176459T3 (es) | Patrones y soluciones de contraste estabilizados. | |
SE9202208D0 (sv) | Vaevnadsfoerstaerkning | |
ATE309826T1 (de) | Wirkstoffhaltige pflaster | |
ATE223206T1 (de) | Verfahren zur herstellung von mikropartikeln | |
DE69514354D1 (de) | Verfahren zur herstellung von verbesserten biologischen pestiziden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |